Kaival Brands Innovations Group, Inc. (KAVL) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential
Current Price
$0.02
Price Target
—
Target Range
— — —
Analyst Rating
—
Forward P/E—
Trailing P/E-0.0x
Forward PEG—
Implied Growth—
Median Target—
Analyst Spread—
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$—
—
Consensus
$—
—
Bull Case
$—
—
KAVL Price Target Analysis
Updated May 8, 2026As of May 8, 2026, Kaival Brands Innovations Group, Inc. (KAVL) has a Wall Street consensus price target of N/A, based on estimates from 0 covering analysts. The company has a market capitalization of $238223.
Analyst price targets range from a low of N/A to a high of N/A.
The current analyst consensus rating is N/A, with 0 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, KAVL trades at a trailing P/E of -0.0x.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Consumer Defensive stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+17.1%
Avg Forward P/E17.1x
Peers with Coverage7 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 XXII22nd Century Group, Inc. | $118791 | $0.71 | — | — | — | — | — |
 TPVGTriplePoint Venture Growth BDC Corp. | $243M | $5.99 | $8.95 | +49.4% | Hold | 6.5x | 12 |
 GNLNGreenlane Holdings, Inc. | $320058 | $5.34 | — | — | — | — | — |
 CNTXContext Therapeutics Inc. | $214M | $2.33 | $5.25 | +125.3% | Buy | — | 6 |
 MOAltria Group, Inc. | $115.4B | $69.04 | $68.50 | -0.8% | Buy | 12.2x | 26 |
 PMPhilip Morris International Inc. | $266.7B | $171.10 | $187.60 | +9.6% | Buy | 20.4x | 25 |
 BTIBritish American Tobacco p.l.c. | $125.9B | $58.07 | $40.00 | -31.1% | Buy | 16.1x | 18 |
 IIPRInnovative Industrial Properties, Inc. | $1.6B | $56.61 | $44.00 | -22.3% | Hold | 13.2x | 11 |
 CRONCronos Group Inc. | $981M | $2.57 | $2.30 | -10.5% | Hold | 34.3x | 15 |
 MAPSWM Technology, Inc. | $18M | $0.37 | — | — | — | — | — |
Upside Potential Comparison
CNTXTPVGPMMOCRONIIPRBTISee KAVL's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs KAVL Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare KAVL vs WMT
Side-by-side business, growth, and profitability comparison vs Walmart Inc..
Start ComparisonKAVL — Frequently Asked Questions
Quick answers to the most common questions about buying KAVL stock.
What is the KAVL stock price target for 2026?
The consensus price target for KAVL is $N/A, close to the current price of $0.0176 (N/A% implied move). Based on 0 analyst estimates, the stock appears fairly valued near current levels.
Is KAVL a buy, sell, or hold?
KAVL has a consensus rating of "N/A" based on 0 Wall Street analysts. The rating breakdown is mixed, with 0 Hold ratings making up the largest segment. The consensus 12-month price target of $N/A implies N/A% upside from current levels.
Is KAVL stock overvalued or undervalued?
KAVL's current price is $0.0176 with a consensus target of $N/A (N/A% implied move). Analyst estimates suggest the stock is fairly valued at current levels.
How high can KAVL stock go?
The most bullish Wall Street analyst has a price target of $N/A for KAVL, while the most conservative target is $N/A. The consensus of $N/A represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover KAVL stock?
KAVL is lightly followed, with 0 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 0 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the KAVL stock forecast?
The 12-month KAVL stock forecast based on 0 Wall Street analysts shows a consensus price target of $N/A, with estimates ranging from $N/A (bear case) to $N/A (bull case). The median consensus rating is "N/A".
Should I buy KAVL stock?
KAVL appears fairly valued according to analysts, with a "N/A" rating and minimal upside to the $N/A target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do KAVL price targets vary so much?
KAVL analyst price targets range from $N/A to $N/A, a NaN% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $N/A consensus represents the middle ground.